© 2005 Oxford University Press
Novel post DNA synthesis chemistry for preparing oligonucleotides containing O6-modified purines
Centre for Chemical Biology, Department of Chemistry, Richard Roberts Building, University of Sheffield, Sheffield S3 7HF, UK
O6-Alkylguanine DNA alkyltransferase (AGT) is a key target for inhibition during cancer chemotherapy. A large number of O6-modified-guanine analogues have been developed as AGT inhibitors, of which benzyl and (4-bromothenyl) have been used clinically. Since the normal AGT substrate is the alkylated guanine in DNA, the inhibition of AGT by oligonucleotides containing these compounds offers a promising therapeutic approach in terms of efficacy. In order to prepare such oligonucleotides, we have synthesised the novel phosphoramidite analogue of the 2'-deoxyriboside of 2-amino-6-methylsulfonylpurine. Following the incorporation of the analogue into DNA, the subsequent nucleophilic displacement of the methylsulfanyl group by alkoxide provides a convenient route to a variety of oligonucleotides containing O6-modified guanines.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. J. Pearson, S. Wharton, A. J. Watson, G. Begum, A. Butt, N. Glynn, D. M. Williams, T. Shibata, M. F. Santibanez-Koref, and G. P. Margison A novel DNA damage recognition protein in Schizosaccharomyces pombe. Nucleic Acids Res., January 1, 2006; 34(8): 2347 - 2354. [Abstract] [Full Text] [PDF] |
||||
